EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration

Rabeea Razaq, Arslan Younas, Muhammad Azam Qamar iD, Ahmad Farhan iD, Aman Khalid, Amna Akhtar, Muntaha Anwar, Tania Shad, Zulfiqar Ahmad Rehan iD, Syed Imran Hassan iD

Molecules · 24.06.2026 · 31 (13) · 2225

DOI: 10.3390/molecules31132225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 24.06.2026. Verfasst von Rabeea Razaq und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Nanostructures, Artificial Intelligence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surface-enhanced Raman spectroscopy (SERS) has emerged as a transformative tool in biomedical diagnostics, offering a highly sensitive and non-invasive method for detecting molecular biomarkers at exceptionally low concentrations. This approach takes advantage of the plasmonic characteristics of customized metallic nanostructures that produce intense localized electromagnetic fields via localized surface plasmon resonance and facilitate electron transfer reactions that notoriously enhance the intrinsically weak Raman scattering signals of molecular entities which reside on or next to their surfaces. SERS-based assays have shown remarkable potential in detecting cancer biomarkers, circulating tumor DNA (ctDNA), and proteins at early stages, enabling timely and targeted intervention. Additionally, the combination of SERS with AI-driven data analysis has facilitated real-time diagnostics, enhancing the precision and efficiency of point-of-care testing. Despite its promising capabilities, challenges such as substrate fouling, signal degradation, and the need for better biocompatibility remain. Nevertheless, ongoing research in substrate development, coupled with advances in AI, positions SERS as a leading technology for future diagnostic tools. This paper explores the current state of SERS in biomedical applications, highlighting its potential to revolutionize diagnostics and personalized medicine while addressing the existing limitations and future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrum Analysis, RamanNanostructuresArtificial IntelligenceHumansSurface Plasmon ResonancePrecision MedicineBiomarkers, Tumor

Stichwörter der Autor:innen

artificial intelligencebiomedical diagnosticsearly disease detectionpersonalized medicinesurface-enhanced raman spectroscopy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
  • Department of Chemistry, School of Science, University of Management and Technology, Lahore 54770, Pakistan.
  • International Center for Interdisciplinary Research in Sciences, The University of Lahore, Lahore 54000, Pakistan.
  • School of Mechanical, Medical and Process Engineering, Faculty of Engineering, Queensland University of Technology, Brisbane, QLD 4000, Australia.
  • Department of Energy Systems Engineering, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
  • Department of Zoology, Wildlife and Fisheries, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.

ORCID-Profile: Muhammad Azam Qamar, Ahmad Farhan, Zulfiqar Ahmad Rehan, Syed Imran Hassan

Zitieren

APA

Razaq, R., Younas, A., Qamar, M. A., Farhan, A., Khalid, A., Akhtar, A., Anwar, M., Shad, T., Rehan, Z. A., & Hassan, S. I. (2026). Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration. Molecules, 31(13), 2225. https://doi.org/10.3390/molecules31132225

Vancouver

Razaq R, Younas A, Qamar MA, Farhan A, Khalid A, Akhtar A, et al. Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration. Molecules. 2026;31(13):2225. doi:10.3390/molecules31132225

BibTeX
@article{Razaq2026,
  author = {Razaq, Rabeea and Younas, Arslan and Qamar, Muhammad Azam and Farhan, Ahmad and Khalid, Aman and Akhtar, Amna and Anwar, Muntaha and Shad, Tania and Rehan, Zulfiqar Ahmad and Hassan, Syed Imran},
  title = {Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {13},
  pages = {2225},
  doi = {10.3390/molecules31132225}
}
Kostenlos starten →